Published in J Appl Physiol (1985) on July 01, 1985
A friend to the airways: a review of the emerging clinical importance of the bronchial arterial circulation. Surg Radiol Anat (2012) 1.67
Dose-related effects of pharmacological mediators on tracheal vascular resistance in dogs. Br J Pharmacol (1987) 0.94
H1- and H2-receptor characterization in the tracheal circulation of sheep. Br J Pharmacol (1988) 0.86
Assessment of bronchodilatation after spontaneous recovery from a histamine challenge in asthmatic children. Thorax (1992) 0.81
The airway microvasculature and exercise induced asthma. Thorax (1992) 0.77
Intrapulmonary bronchial blood flow of rats as studied by the microsphere method. Heart Vessels (1991) 0.77
Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung. Br J Clin Pharmacol (1992) 0.75
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99
A look into the nature and causes of human errors in the intensive care unit. Crit Care Med (1995) 5.14
Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J (2002) 4.68
The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35
Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37
Plasma cortisol levels in patients with septic shock. Crit Care Med (1990) 2.33
High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32
Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine. Crit Care Med (1998) 2.14
Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12
The lactoperoxidase system functions in bacterial clearance of airways. Am J Respir Cell Mol Biol (2000) 2.08
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
Influence of exercise intensity and duration on biochemical adaptations in skeletal muscle. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.73
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis (1992) 1.73
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Clinical aspects of mucociliary transport. Am Rev Respir Dis (1977) 1.61
The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53
Living related donation in lung transplantation. Ethical considerations. Arch Intern Med (1995) 1.53
Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51
Why have new effective therapies for sepsis not been developed? Crit Care Med (1994) 1.50
Treatment of mucociliary dysfunction. Chest (1996) 1.45
Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? Yes. Am J Respir Crit Care Med (1995) 1.43
Blast lung injury from an explosion on a civilian bus. Chest (1999) 1.42
HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med (1994) 1.40
Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther (2002) 1.40
Acquired immunodeficiency syndrome and critical care. Crit Care Med (1990) 1.39
Histamine H2-receptors in the sheep bronchus and cat trachea: the action of burimamide. Br J Pharmacol (1973) 1.38
Effects of anaphylaxis and chemical histamine liberators in sheep. J Comp Pathol (1970) 1.34
Pharmacology of bovine pulmonary vein anaphylaxis in vitro. Br J Pharmacol (1971) 1.34
Definition of sepsis. Intensive Care Med (2001) 1.34
A look into the nature and causes of human errors in the intensive care unit. 1995. Qual Saf Health Care (2003) 1.31
Acute systemic anaphylaxis in the calf. Br J Pharmacol (1973) 1.31
Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis (1975) 1.28
ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24
Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am Rev Respir Dis (1978) 1.24
Effects of histamine and 5-hydroxytryptamine on sheep. J Comp Pathol (1967) 1.24
The Schultz-Dale reaction in bovine pulmonary smooth muscles. Br J Pharmacol (1970) 1.18
Classification and biological distribution of histamine receptor sub-types. Agents Actions (1975) 1.16
Immunologic release of histamine from bovine polymorphonuclear leukocytes. Am J Vet Res (1975) 1.16
Some pharmacodynamic effects of the nematocides: methyridine, tetramisole and pyrantel. J Pharm Pharmacol (1970) 1.16
The pharmacology of anaphylaxis in the chicken intestine. Br J Pharmacol (1976) 1.16
Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am J Respir Crit Care Med (1996) 1.14
Studies of prostaglandins and prostaglandin antagonists on bovine pulmonary vein in vitro. Prostaglandins (1974) 1.14
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses. J Med Chem (1999) 1.12
Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther (2009) 1.12
Production of kinins in bovine anaphylactic shock. Br J Pharmacol (1972) 1.11
The Schultz-Dale reaction: a review. Agents Actions (1978) 1.11
Methotrexate: does it treat or induce asthma? Am Rev Respir Dis (1991) 1.11
Some cardiovascular and respiratory effects of prostaglandins E1, E2 and F2 alpha in the calf. Prostaglandins (1972) 1.10
Release of dopamine from bovine lung by specific antigen and by compound 48-80. Br J Pharmacol (1971) 1.10
Factors in delayed muscle soreness. Med Sci Sports (1977) 1.09
Spasmolytic action of histamine in airway smooth muscle of horse. Agents Actions (1978) 1.09
Bronchial circulation in asthma. Respiration (1985) 1.08
Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med (1995) 1.07
Holy consent--a dilemma for medical staff when maternal consent is withheld for emergency caesarean section. Int J Obstet Anesth (2006) 1.07
Cyclic AMP-dependent phosphorylation of a 26 kD axonemal protein in ovine cilia isolated from small tissue pieces. Am J Respir Cell Mol Biol (1993) 1.06
Modulation of the formation and release of bovine SRS-A in vitro by several anti-anaphylactic drugs. Int Arch Allergy Appl Immunol (1975) 1.06
The immunological release of slow-reacting substance of anaphylaxis from bovine lung. Can J Physiol Pharmacol (1974) 1.04
Characterization of a late phase pulmonary response after antigen challenge in allergic sheep. Am Rev Respir Dis (1983) 1.03
The presence of inhibitory histamine H-2-receptors in guinea-pig tracheobronchial muscle. J Pharm Pharmacol (1978) 1.03
Hemodynamic alterations of heat stroke in the elderly. Chest (1979) 1.03
Evidence for increased permeability in reexpansion pulmonary edema. Am J Med (1981) 1.03
Is the physician's duty to the individual patient or to society? Crit Care Med (1995) 1.02
The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study. J Med Ethics (2006) 1.02
Histamine release from calf lung in vitro by specific antigen and by compound 48-80. Arch Int Pharmacodyn Ther (1971) 1.01
Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest (1981) 1.01
Preliminary evidence for two subclasses of histamine H2-receptors. Agents Actions (1979) 1.01
Effect of high-frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis. Chest (1998) 1.01
Protein kinase C-dependent phosphorylation of a ciliary membrane protein and inhibition of ciliary beating. J Cell Sci (1993) 1.00
An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med (1984) 0.99
Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med (1999) 0.99
Bronchial tissue kallikrein activity is regulated by hyaluronic acid binding. Am J Respir Cell Mol Biol (1999) 0.99
Relation of colloid osmotic pressure to arterial hypoxemia and cerebral edema during crystalloid volume loading of patients with diabetic ketoacidosis. Ann Intern Med (1982) 0.98
Isolation and characterization of a peroxidase from the airway. Am J Respir Cell Mol Biol (1997) 0.97
Cutaneous vascular permeability factors (histamine, 5-hydroxytryptamine, bradykinin) and passive cutaneous anaphylaxis in sheep. J Pharm Pharmacol (1970) 0.97
A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm Pharmacol (1990) 0.97
Bovine lung parenchyma strip has both airway and vascular characteristics. (Pharmacological comparisons with bronchus, pulmonary artery and vein). Res Commun Chem Pathol Pharmacol (1980) 0.96
Foregoing life-sustaining treatment in an Israeli ICU. Intensive Care Med (1998) 0.96
The process of intensive care triage. Intensive Care Med (2001) 0.96
Mechanism of hydrogen peroxide-induced inhibition of sheep airway cilia. Am J Respir Cell Mol Biol (1992) 0.95
Hematological and pathological changes in acute systemic anaphylaxis in calves: effects of pharmacological agents. Can J Comp Med (1973) 0.95
Relaxant action of histamine on rabbit trachea: possible existence of third histamine receptor subtype. Res Commun Chem Pathol Pharmacol (1979) 0.95
Autacoid and anaphylactic reactivity of pulmonary and hepatic smooth musculature of the cat. Eur J Pharmacol (1977) 0.94
Mechanisms of metabisulfite-induced bronchoconstriction: evidence for bradykinin B2-receptor stimulation. J Appl Physiol (1985) (1992) 0.94
Mucociliary interaction in vitro: effects of physiological and inflammatory stimuli. J Appl Physiol (1985) (1990) 0.94
Parental self-efficacy and morbidity in pediatric asthma. J Asthma (2001) 0.94
Effects of P. aeruginosa-derived bacterial products on tracheal ciliary function: role of O2 radicals. Am J Physiol (1991) 0.94
Nasopharyngeal airway: a facilitated access to the trachea. For nasotracheal suction, bedside bronchofiberscopy, and selective bronchography. Ann Intern Med (1971) 0.94
Role of H1- and H2-receptors in airway reactions to histamine in conscious sheep. J Appl Physiol Respir Environ Exerc Physiol (1980) 0.94
The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis (1981) 0.94